Image

A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants with Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma

Examining side effects of Epcoritamab for lymphoma patients in outpatient care.

Recruiting
18 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

Study Overview: This study is for adults with a type of blood cancer called B-cell Lymphoma. The specific types are relapsed or refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) and Classic Follicular Lymphoma (cFL). "Relapsed" means the cancer came back after treatment, and "refractory" means it didn't respond to treatment. The study tests a new drug called epcoritamab to see if it's safe. Epcoritamab is given by injection under the skin (subcutaneous) and participants will get increasing doses until the full dose is reached.

Key Details:

  • Duration: Participants will receive treatment in 28-day cycles.
  • Location: The study takes place at about 80 sites in the USA.
  • Participation: Regular visits to a clinic or hospital are required, with frequent checks through medical tests.

Adults who have tried at least 1 prior treatment for DLBCL or 2 for cFL may join. They must have a life expectancy of more than 3 months and meet specific health conditions. Those with certain infections or central nervous system involvement cannot join. The study aims to enroll about 184 adults.

Print
Study details
    Diffuse Large B-Cell Lymphoma
    Classic Follicular Lymphoma

NCT05451810

Genmab

11 January 2025

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.